Alerts
Want to monitor CSTL?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor CSTLWant to monitor CSTL?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor CSTLCastle Biosciences is a commercial-stage dermatologic cancer company focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The Company currently offers tests for patients with cutaneous melanoma (DecisionDx®-Melanoma, DecisionDx®-CMSeq), cutaneous squamous cell carcinoma (DecisionDx®-SCC), suspicious pigmented lesions (DecisionDx® DiffDx™-Melanoma) and uveal melanoma (DecisionDx®-UM, DecisionDx®-PRAME and DecisionDx®-UMSeq). Castle also has active research and development programs for tests in other dermatologic diseases with high clinical need.